New MRI Findings in Fukuyama Congenital Muscular Dystrophy: Brain Stem and Venous System Anomalies

References

1. 1.↵
   1. Aida N,
   2. Tamagawa K,
   3. Takada K, et al

   . Brain MR in Fukuyama congenital muscular dystrophy. AJNR Am J Neuroradiol 1996;17:605–13 pmid:8730178

   Abstract
2. 2.
   1. Aida N

   . Fukuyama congenital muscular dystrophy: a neuroradiologic review. J Magn Reson Imaging 1998;8:317–26 doi:10.1002/jmri.1880080211 pmid:9562058

   CrossRefPubMed
3. 3.↵
   1. Clement E,
   2. Mercuri E,
   3. Godfrey C, et al

   . Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008;64:573–82 doi:10.1002/ana.21482 pmid:19067344

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Itoh M,
   2. Houdou S,
   3. Kawahara H, et al

   . Morphological study of the brainstem in Fukuyama type congenital muscular dystrophy. Pediatr Neurol 1996;15:327–31 doi:10.1016/S0887-8994(96)00230-5 pmid:8972533

   CrossRefPubMed
5. 5.↵
   1. Saito Y,
   2. Kobayashi M,
   3. Itoh M, et al

   . Aberrant neuronal migration in the brainstem of Fukuyama-type congenital muscular dystrophy. J Neuropathol Exp Neurol 2003;62:497–508 doi:10.1093/jnen/62.5.497 pmid:12769189

   CrossRefPubMed
6. 6.↵
   1. Nakano I,
   2. Funahashi M,
   3. Takada K, et al

   . Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus. Acta Neuropathol 1996;91:313–21 doi:10.1007/s004010050431 pmid:8834545

   CrossRefPubMed
7. 7.↵
   1. Wood AJ,
   2. Muller JS,
   3. Jepson CD, et al

   . Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency. Hum Mol Genet 2011;20:4879–90 doi:10.1093/hmg/ddr426 pmid:21926082

   CrossRefPubMed
8. 8.↵
   1. Sugino S,
   2. Miyatake M,
   3. Ohtani Y, et al

   . Vascular alterations in Fukuyama type congenital muscular dystrophy. Brain Dev 1991;13:77–81 doi:10.1016/s0387-7604(12)80110-0 pmid:1892223

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Moore SA,
   2. Saito F,
   3. Chen J, et al

   . Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002;418:422–25 doi:10.1038/nature00838 pmid:12140559

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Saito Y,
    2. Yamamoto T,
    3. Mizuguchi M, et al

    . Altered glycosylation of alpha-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains. Brain Res 2006;1075:223–28 doi:10.1016/j.brainres.2005.12.108 pmid:16466646

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Fukuyama Y,
    2. Osawa M,
    3. Suzuki H

    . Congenital progressive muscular dystrophy of the Fukuyama type: clinical, genetic and pathological considerations. Brain Dev 1981;3:1–29 doi:10.1016/S0387-7604(81)80002-2 pmid:7258547

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Yamamoto T,
    2. Shibata N,
    3. Kanazawa M, et al

    . Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation. Acta Neuropathol 1997;94:173–79 doi:10.1007/s004010050690 pmid:9255393

    CrossRefPubMed
13. 13.↵
    1. Hosokawa H,
    2. Ninomiya H,
    3. Kitamura Y, et al

    . Vascular endothelial cells that express dystroglycan are involved in angiogenesis. J Cell Sci 2002;115:1487–96 pmid:11896196

    Abstract/FREE Full Text
14. 14.↵
    1. Kato I,
    2. Osawa M,
    3. Murasugi S, et al

    . Neuroimaging morphological study of brain stem and cerebellum in cases of Fukuyama type congenital muscular dystrophy. Journal of Tokyo Women’s Medical University 1998;68:772–78